Notice of Public Forum; Extension of Comment Period, 65259 [2022-23530]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 208 / Friday, October 28, 2022 / Notices
officer of the Commission to represent
the interests of the general public in the
proceeding, pursuant to 39 U.S.C. 505
(Public Representative). Section II also
establishes comment deadline(s)
pertaining to each request.
The public portions of the Postal
Service’s request(s) can be accessed via
the Commission’s website (https://
www.prc.gov). Non-public portions of
the Postal Service’s request(s), if any,
can be accessed through compliance
with the requirements of 39 CFR
3011.301.1
The Commission invites comments on
whether the Postal Service’s request(s)
in the captioned docket(s) are consistent
with the policies of title 39. For
request(s) that the Postal Service states
concern market dominant product(s),
applicable statutory and regulatory
requirements include 39 U.S.C. 3622, 39
U.S.C. 3642, 39 CFR part 3030, and 39
CFR part 3040, subpart B. For request(s)
that the Postal Service states concern
competitive product(s), applicable
statutory and regulatory requirements
include 39 U.S.C. 3632, 39 U.S.C. 3633,
39 U.S.C. 3642, 39 CFR part 3035, and
39 CFR part 3040, subpart B. Comment
deadline(s) for each request appear in
section II.
II. Docketed Proceeding(s)
1. Docket No(s).: MC2023–25 and
CP2023–24; Filing Title: USPS Request
to Add Priority Mail Express, Priority
Mail, First-Class Package Service &
Parcel Select Contract 73 to Competitive
Product List and Notice of Filing
Materials Under Seal; Filing Acceptance
Date: October 21, 2022; Filing Authority:
39 U.S.C. 3642, 39 CFR 3040.130
through 3040.135, and 39 CFR 3035.105;
Public Representative: Jethro Dely;
Comments Due: October 31, 2022.
This Notice will be published in the
Federal Register.
Erica A. Barker,
Secretary.
[FR Doc. 2022–23450 Filed 10–27–22; 8:45 am]
BILLING CODE 7710–FW–P
PRIVACY AND CIVIL LIBERTIES
OVERSIGHT BOARD
lotter on DSK11XQN23PROD with NOTICES1
[Notice-PCLOB–2022–02; Docket No. 2022–
0009; Sequence No. 2]
Notice of Public Forum; Extension of
Comment Period
Privacy and Civil Liberties
Oversight Board (PCLOB).
AGENCY:
1 See Docket No. RM2018–3, Order Adopting
Final Rules Relating to Non-Public Information,
June 27, 2018, Attachment A at 19–22 (Order No.
4679).
VerDate Sep<11>2014
22:30 Oct 27, 2022
Jkt 259001
ACTION:
Notice; Extension of comment
period.
The PCLOB, or Board, is
extending the comment period for the
notice announcing a request for
comments on the Board’s Oversight
Project examining Section 702 of the
Foreign Intelligence Surveillance Act
(FISA) that appeared in the Federal
Register of September 26, 2022.
DATES: The Board is extending the
comment period announced in the
notice and request for comments
published on September 26, 2022 (87 FR
58393) to Friday, November 4, 2022.
FOR FURTHER INFORMATION CONTACT:
Alan Silverleib, Public and Legislative
Affairs Officer at 202–997–7719; pao@
pclob.gov.
SUMMARY:
Lois D. Mandell,
Director, Regulatory Secretariat Division,
Office of Government-Wide Policy, General
Services Administration.
[FR Doc. 2022–23530 Filed 10–27–22; 8:45 am]
BILLING CODE 6820–B5–P
OFFICE SCIENCE AND TECHNOLOGY
POLICY
Request for Information on Data
Collection for Emergency Clinical
Trials and Interoperability Pilot
Office of Science and
Technology Policy (OSTP).
ACTION: Notice of Request for
Information (RFI) on Data Collection for
Emergency Clinical Trials and
Interoperability Pilot.
AGENCY:
As described in the recent RFI
on Clinical Research Infrastructure and
Emergency Clinical Trials, the White
House Office of Science and Technology
Policy (OSTP), in partnership with the
National Security Council (NSC), is
leading efforts to ensure that
coordinated and large-scale clinical
trials can be efficiently carried out
across a range of institutions and sites
as needed to address outbreaks of
disease and other emergencies. In this
RFI on Data Collection for Emergency
Clinical Trials and Interoperability
Pilot, issued in partnership with the
Office of the National Coordinator for
Health Information Technology (ONC),
OSTP and ONC seek input on viable
technical strategies to distribute clinical
trial protocols and capture clinical trial
data using common application
programming interfaces (APIs), in the
pre-emergency phase as well as in
emergency settings. One specific
objective for this RFI is to gather
information about whether there is
SUMMARY:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
65259
value in a pilot or demonstration project
to operationalize data capture in the
near term, for example within 6–12
months of the close of comments on this
RFI.
DATES: Interested persons and
organizations are invited to submit
comments on or before 5:00 p.m. ET on
December 27, 2022.
ADDRESSES: Interested individuals and
organizations should submit comments
electronically to
datacollectionforclinicaltrials@
ostp.eop.gov and include ‘‘Data
Collection for Clinical Trials RFI’’ in the
subject line of the email. Due to time
constraints, mailed paper submissions
will not be accepted, and electronic
submissions received after the deadline
cannot be ensured to be incorporated or
taken into consideration.
Instructions
Response to this RFI is voluntary.
Each responding entity (individual or
organization) is requested to submit
only one response. Please feel free to
respond to one or as many prompts as
you choose.
Please be concise with your
submissions, which must not exceed 10
pages in 12-point or larger font, with a
page number on each page. Responses
should include the name of the
person(s) or organization(s) filing the
comment.
OSTP invites input from all
stakeholders including members of the
public, representing all backgrounds
and perspectives. In particular, OSTP is
interested in input from health
information technology (health IT)
companies, app developers, clinical trial
designers, and users of health IT
products. Please indicate which of these
stakeholder types, or what other
description, best fits you as a
respondent. If a comment is submitted
on behalf of an organization, the
individual respondent’s role in the
organization may also be provided on a
voluntary basis.
Comments containing references,
studies, research, and other empirical
data that are not widely published
should include copies or electronic
links of the referenced materials. No
business proprietary information,
copyrighted information, or personally
identifiable information should be
submitted in response to this RFI. Please
be aware that comments submitted in
response to this RFI may be posted on
OSTP’s website or otherwise released
publicly.
In accordance with FAR 15.202(3),
responses to this notice are not offers
and cannot be accepted by the Federal
E:\FR\FM\28OCN1.SGM
28OCN1
]]>Agencies
[Federal Register Volume 87, Number 208 (Friday, October 28, 2022)]
[Notices]
[Page 65259]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23530]
=======================================================================
-----------------------------------------------------------------------
PRIVACY AND CIVIL LIBERTIES OVERSIGHT BOARD
[Notice-PCLOB-2022-02; Docket No. 2022-0009; Sequence No. 2]
Notice of Public Forum; Extension of Comment Period
AGENCY: Privacy and Civil Liberties Oversight Board (PCLOB).
ACTION: Notice; Extension of comment period.
-----------------------------------------------------------------------
SUMMARY: The PCLOB, or Board, is extending the comment period for the
notice announcing a request for comments on the Board's Oversight
Project examining Section 702 of the Foreign Intelligence Surveillance
Act (FISA) that appeared in the Federal Register of September 26, 2022.
DATES: The Board is extending the comment period announced in the
notice and request for comments published on September 26, 2022 (87 FR
58393) to Friday, November 4, 2022.
FOR FURTHER INFORMATION CONTACT: Alan Silverleib, Public and
Legislative Affairs Officer at 202-997-7719; [email protected].
Lois D. Mandell,
Director, Regulatory Secretariat Division, Office of Government-Wide
Policy, General Services Administration.
[FR Doc. 2022-23530 Filed 10-27-22; 8:45 am]
BILLING CODE 6820-B5-P
